Navigation Links
Pelleve(TM) Wrinkle Treatment System Featured On 'Beauty Spaces' TV Show
Date:10/14/2009

OCEANSIDE, N.Y., Oct. 14 /PRNewswire/ -- Pelleve(TM), a skin tightening system for the nonsurgical treatment of wrinkles, will be seen in 120 million homes across the country this weekend on The Learning Channel's (TLC) "Beauty Spaces," a show that brings consumers the latest in beauty innovation and education. Created by the producers of the award-winning show "Designing Spaces," "Beauty Spaces" interviewed Dr. Michael Stampar to learn how Pelleve(TM) can help patients achieve a more youthful appearance with virtually no pain and little downtime.

The show airs nationally on TLC (Saturday at 7:00AM Eastern) and We(TM) (Friday at 7:30AM Eastern), as well as in Atlanta, Baltimore, Charlotte, Chicago, Dallas, Houston, Los Angeles, San Francisco and Tampa this week.

Dr. Michael Stampar, a board-certified facial plastic surgeon from Punta Gorda, Florida, demonstrated the Pelleve(TM) Wrinkle Treatment System with patients Linda Hendrick and Mimi Evans.

"Pelleve(TM) works by gradually and progressively heating the skin with a warming device to stimulate new collagen production, which results in the appearance of firmer skin," said Dr. Stampar. "Unlike other skin tightening procedures, Pelleve(TM) is virtually painless. Because we're raising the temperature of the skin gradually instead of suddenly, the patient experiences the feeling of a warm facial massage."

Stampar explained that immediately after the procedure, patients should expect to see skin that appears firmer and tighter. The overall result is a noticeable improvement in skin quality and appearance with minimal side effects and recovery time.

When asked who may be a candidate for Pelleve(TM), Dr. Stampar indicated that patients should speak to their physicians about whether Pelleve(TM) is appropriate for them based on their skin type, age, and what they hope to accomplish by having the procedure.

"The biggest advantage over other skin tightening procedures is that with Pelleve(TM), I can get a successful result every time," said Dr. Stampar. When asked what he'd like patients to know about the Pelleve(TM) Wrinkle Treatment System, Stampar replied, "Getting a Pelleve(TM) treatment turns back the clock on the aging process and may help slow the progression of facial wrinkles, folds and loose skin that can lead patients to seek surgery later."

"We're excited to bring the next generation of skin-tightening technology to a national audience," said Tom Harper, Executive Vice President of Global Marketing for Ellman International, which developed the Pelleve(TM) Wrinkle Treatment System. "The opportunity to be featured on We and TLC is a step forward for Pelleve(TM), as consumers have the chance to learn about the procedure and how it may help them achieve their aesthetic goals."

Pelleve(TM) was introduced to the U.S. market earlier this year through dermatologists, plastic surgeons, ENTs and other cosmetic surgery clinics.

To see Pelleve(TM) on "Beauty Spaces" via the web, visit www.designingspaces.tv.

For more information about Pelleve(TM) or to locate doctors trained in using the Pelleve(TM) Wrinkle Treatment System, visit www.pelleve.com or call 1-877-KNOW-PELLEVE.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) is a privately held manufacturer of medical devices used to perform a variety of aesthetic and surgical procedures. The company's products are based on patented and proprietary technologies utilizing high frequency radiowaves to perform precision electrosurgery and laser procedures in the medical, dental and veterinary specialties. For more information, please visit www.ellman.com

SOURCE Ellman International


'/>"/>
SOURCE Ellman International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
2. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
3. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
6. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
7. Eastern Europes First Novalis Tx(TM) Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc(R) Technology
8. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Metabolic Solutions Development Company To Test Potential Treatment for Alzheimers
11. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
Breaking Medicine News(10 mins):